Alnylam Pharmaceuticals Inc (ALNY)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$20.31B
EV to revenue ratio (TTM)
3.72
EV to ebitda
16.39
Financial Performance
Revenue (TTM)
$5.01B
Gross profit (TTM)
$3.87B
EBITDA
$1.03B
Profitability
Operating margin (TTM)
23.70%
Profit margin
52.80%
Return on assets (TTM)
9.51%
Return on equity (TTM)
138.10%
Per Share Metrics
Revenue per share (TTM)
$37.65
EPS
$19.80
Diluted EPS (TTM)
$19.80
Book value
$26.92
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
7.66
Trailing P/E
7.66
Forward P/E
12.25
PEG ratio
0.21
Price to sales ratio (TTM)
4.05
Price to book ratio (TTM)
5.82
Growth
Quarterly earnings growth (YoY)
16.70%
Quarterly revenue growth (YoY)
633.00%
Analyst Sentiment
Strong buy
7
Buy
15
Hold
8
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.44